MR1 and glioblastoma: We observed different levels of MR1 staining of the tumor cells in primary versus recurrent GBM, with 0 versus 1 patients showing no (−), 4 versus 2 patients showing low (+), 4 versus 10 patients showing medium (++), and 11 versus 6 showing high (+++) staining.